Bone Loss

Bone drugs may not protect osteoporotic women from breast cancer


Osteoporosis drugs known as bisphosphonates may not protect women from breast cancer as had been thought, according to a new study.

Guidance to prevent fractures in cancer-associated bone disease


The epidemiology and pathophysiology of cancer-associated bone disease was reviewed in a new paper published by an International Osteoporosis Foundation (IOF) Committee of Scientific Advisors Working Group.

Calcium/vitamin D don't stop bone loss in breast cancer


A review of calcium and vitamin D supplementation trials revealed that current recommended doses are inadequate to prevent bone mineral density loss in women undergoing breast cancer therapy.

A roundup of FDA news from June 2013


FDA-related news items of relevance from the month of June, 2013.

Burden of giant-cell tumor of the bone reduced by denosumab


When patients with giant-cell tumor of the bone were treated with denosumab, which is a drug targeted against a protein that promotes bone destruction, the number of tumor giant cells decreased and new bone formation increased.

Calcium and vitamin D may hurt, not help, in prostate cancer

Calcium and/or vitamin D supplementation at commonly recommended doses does not prevent bone loss from androgen-deprivation therapy.

Denosumab Better for Breast Cancer With Bone Metastases

Denosumab Better for Breast Cancer With Bone Metastases

Denosumab better prevents skeletal complications, ups health-related QoL versus zoledronic acid.

Gum disease may affect HPV status of head-and-neck tumors

A history of periodontitis may be associated with an increased risk of HPV-positive tumors in persons with head and neck squamous cell carcinoma.

BMD loss occurs early in androgen deprivation therapy

BMD loss occurs early in androgen deprivation therapy

Study finds loss evident in men treated with ADT for nonmetastatic, hormone-sensitive prostate cancer.

Bone loss risk highlighted

The risk of bone loss resulting from breast and prostate cancer treatment has been highlighted by researchers in Canada.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs